Close menu




September 26th, 2025 | 07:35 CEST

Gerresheimer, dynaCERT, Volkswagen – Exciting developments!

  • Hydrogen
  • greenhydrogen
  • cleantech
  • Electromobility
  • Healthcare
  • Pharma
Photo credits: pixabay.com

News drives prices. However, the pendulum can swing in both directions. For informed investors, the correct interpretation of events is crucial. Often, this then leads to lucrative entry and exit signals. Gerresheimer was the latest to be hit, but which stock could be next? However, there are also stocks that are due for a realignment, offering opportunities for rising prices.

time to read: 3 minutes | Author: Carsten Mainitz
ISIN: GERRESHEIMER AG | DE000A0LD6E6 , DYNACERT INC. | CA26780A1084 , VOLKSWAGEN AG VZO O.N. | DE0007664039

Table of contents:


    Gerresheimer – Investor confidence is waning

    One bad piece of news has followed another in recent months for the German packaging manufacturer. From nearly EUR 100 a year ago, the stock is currently trading at around EUR 36. The trigger for the current price slump to a 15-year low of EUR 26.52, followed by a rapid intraday recovery, was the announcement by the German Financial Supervisory Authority (BaFin) that it intends to audit the 2024 consolidated financial statements, including the management report.

    The allegations center on Gerresheimer's alleged violation of accounting regulations. The Company refuted this in a statement and assured that it would cooperate fully with the authorities in clarifying the matter. The Germans are said to have recorded revenues for some customers that have not yet been realized.

    Such announcements are never good, and the share price reaction reflects the shock among investors. Ultimately, however, it should also be noted that only around 5% of the Company's revenues are under scrutiny. The majority of analysts classified the situation in this way: economic dimensions versus investor confidence.

    However, Gerresheimer has been underperforming for some time. The planned sale of the glass-moulded parts division fell through, and most recently, there have been changes in the management board. Overall, investors are dissatisfied with the Company's operating results. The Company lags significantly behind its competitors in terms of profitability and has yet to provide a convincing plan to improve performance. Nevertheless, with a market capitalization of EUR 1.26 billion and a P/E ratio of 11, the shares are currently worth a closer look.

    dynaCERT – Restructuring of financial instruments

    The Canadian company recently announced a major restructuring of its financial instruments. The Company aims to increase its attractiveness to investors and its competitiveness in the dynamic environmental technology sector. The shares are currently trading at CAD 0.135, resulting in a market capitalization of around CAD 69 million. Analysts see significant upside potential in the stock.

    The plan involves reducing the original exercise price of the warrants from CAD 0.28 to CAD 0.20 and extending their term from October 2026 by one year. In addition, the Company plans to reduce the conversion price of the existing convertible bond from CAD 0.24 to CAD 0.15 and extend the maturity of the bond to 2026. These changes could increase the potential number of shares issued from 4.17 million to 6.67 million. The proposed measures are still subject to approval by the Toronto Stock Exchange (TSX).

    dynaCERT is an innovator and pioneer in emission-reduced driving and environmentally friendly heavy-duty operations. Its patented HydraGEN™ technology has been proven to reduce diesel consumption and lower CO2 emissions, creating a new revenue stream for fleet operators via VERRA certification. Freight companies in Europe and North America have been relying on the Canadian company's hydrogen-based solutions for some time. Recently, dynaCERT announced its market entry in Mexico, with an order for 100 units scheduled to be processed over the next 12 months. Growth, however, requires capital. In the summer, the Company raised CAD 5 million to strengthen production and sales. In addition, the completion of its US stock market listing is expected to draw further attention.

    Volkswagen – Market leadership in Europe expanded

    The slight recovery in automotive stocks is currently continuing. Most recently, EU registration figures for August put investors in a good mood. According to the European Automobile Manufacturers' Association (ACEA), registration figures for the first eight months of the year are only 0.1% below the same period last year. The data demonstrates that the VW Group has been able to expand its position as market leader over its competitor, Stellantis.

    In addition, the reduction in US tariffs on vehicle exports from Europe to the US had a positive effect. Although the agreed 15% provides planning security, it still poses a major challenge for many small and medium-sized enterprises. On average, analysts see upside potential of around 20% for Volkswagen's preferred shares over the next 12 months.

    Investor interests

    Business is going well for dynaCERT and Volkswagen. The Canadians stand out clearly from their competitors with their innovative hydrogen technology. This is one of the reasons why analysts attribute multi-bagger potential to the stock. Like several other industry players, VW is continuing its recovery trend thanks to positive EU registration figures and greater planning certainty regarding US tariffs. Gerresheimer, meanwhile, is on the BaFin watch list. The reduced share price is definitely interesting.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Fabian Lorenz on October 17th, 2025 | 07:15 CEST

    Acquisition of Vidac Pharma and Evotec? USD 400 billion at stake for Pfizer, Merck & Co!

    • Biotechnology
    • Biotech
    • Pharma

    Alarm bells are ringing in Big Pharma! Donald Trump appears serious about reducing drug prices. At the same time, patents on blockbuster drugs are expiring, threatening a USD 400 billion revenue shortfall. Pfizer, Merck, and Co. must refill their pipelines. The acquisition merry-go-round is expected to spin even faster in the coming years. Among the potential takeover targets is Vidac Pharma. The Company is still attractively priced, but if its new approach to fighting cancer proves successful in early clinical trials, a multiplication could be possible. And what about Evotec? The Hamburg-based company has repeatedly been traded as a takeover candidate in recent years. However, data and patents are offset by internal problems.

    Read

    Commented by André Will-Laudien on October 17th, 2025 | 07:10 CEST

    E-mobility and hydrogen take off – BYD, Nio, Graphano Energy, and Plug Power in focus!

    • Mining
    • graphite
    • Electromobility
    • Hydrogen
    • Fuelcells
    • renewableenergies

    The German government is resolutely driving forward the transition to e-mobility by 2035 - a clear signal at a time when climate targets and energy dependence are the subject of intense debate. The market for electric vehicles is benefiting from innovations in battery technologies and a growing charging infrastructure. Advances in solid-state batteries, silicon anodes, and new cathode materials are significantly increasing range, performance, and safety. Faster charging times and longer service life are making the switch increasingly attractive for consumers. At the same time, recycling processes and the circular economy are gaining in importance to conserve resources and promote sustainability. With government support and growing competition, enormous opportunities are emerging for manufacturers and investors. But while electromobility is booming, hydrogen is also increasingly becoming the focus of the energy transition as a complementary technology. Investors are free to decide where to invest for the best returns.

    Read

    Commented by Armin Schulz on October 16th, 2025 | 07:20 CEST

    Investors take note: BioNxt Solutions builds on blockbusters from Novo Nordisk and Merck - and has another ace up its sleeve in oncology

    • Biotechnology
    • Biotech
    • Pharma
    • Cancer
    • blockbuster
    • Technology

    In the biotech sector, a single technology can often determine success or failure. Canadian-German company BioNxt Solutions is taking a different approach, relying on three pillars, each targeting major markets and advancing established blockbusters from leading pharmaceutical companies. October has already brought decisive progress, from accelerated patent protection to concrete milestones in development. These concentrated positive signals show that BioNxt Solutions not only has a promising concept, but also the strategy and operational strength to turn it into value. A closer analysis is worthwhile.

    Read